NCT03498521 2025-11-19
CUPISCO
Hoffmann-La Roche
Phase 2 Completed
Clinical Trials
4 trialsNCT02097810 2021-06-09
STARTRK-1
Hoffmann-La Roche
Phase 1 Completed
NCT03961100 2020-09-07
A Performance and Bioavailability Study of Entrectinib in Healthy Volunteers.
Genentech, Inc.
Phase 1 Completed
NCT03330990 2018-08-21
Evaluate the Effect of Entrectinib on the Pharmacokinetics of Midazolam in Cancer Patients
Hoffmann-La Roche
Phase 1 Completed